Evidence map›Paper›PMID 39430502›Full record

ArticleHeliyon2024

Human umbilical cord mesenchymal stem cells on treating osteoarthritis in a rabbit model: Injection strategies.

Zhantao Deng, Xiaoli Zeng, Bofu Lin, Lixuan Chen, Jiwei Wu, Jie Zheng, Yuanchen Ma, Feng-Juan Lyu, Qiujian Zheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhantao DengDepartment of Orthopedics, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Xiaoli ZengGuangdong Xiangxue Stem Cell Regenerative Medicine Technology Co., Ltd, Guangzhou, China.
Bofu LinDepartment of Orthopedics, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Lixuan ChenGuangdong Xiangxue Stem Cell Regenerative Medicine Technology Co., Ltd, Guangzhou, China.
Jiwei WuGuangdong Xiangxue Stem Cell Regenerative Medicine Technology Co., Ltd, Guangzhou, China.
Jie ZhengGuangdong Xiangxue Stem Cell Regenerative Medicine Technology Co., Ltd, Guangzhou, China.
Yuanchen MaDepartment of Orthopedics, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Feng-Juan LyuThe Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Qiujian ZhengDepartment of Orthopedics, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human umbilical cord mesenchymal stem cells (UCMSCs) are a novel stem-cell source to treat osteoarthritis (OA). Here we investigated the therapeutic effects of UCMSCs injection strategies on knee OA in a rabbit model. Thirty OA rabbits randomly received normal saline, a single dose of 1 × 10

Indexed as

Animal modelHuman umbilical cordMesenchymal stem cellsMultiple injectionsOsteoarthritis

Identifiers

PMID39430502
PMCPMC11489144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.